KDR and hepatocellular carcinoma: Another study conducted in HCC established that miR-26a exerted its antiangiogenesis function, at least in part, by inhibiting directly HGF and its downstream signaling pathway, in turn suppressing VEGFA production in HCC cells and impairing VEGFR2-signaling in endothelial cells [51].